Djavid Hadian, MD
Clinical Cardiac Electrophysiology · Goshen, INNPI 1154392678
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,444 of the $5,131 with a category attached, or 86.6%. 34 manufacturers reported payments, led by Medtronic at 24.5% of the total. Reporting peaked in 2024 at $2,012 and has fallen 61.9% since, to $766 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IN, where the typical reported total is $13,586.
Across 205 payments — averaging $25.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Novartis$764
- Pfizer$555
- Boston Scientific$430
- Abiomed$351
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$172
- plus $2K from 28 others
What the payments were for
- Travel & lodging$49810%
- Food & beverage$4,44487%
- Education$1894%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 13 | $1,256 |
| Novartis | 49 | $764 |
| Pfizer | 45 | $555 |
| Boston Scientific | 15 | $430 |
| Abiomed | 3 | $351 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $172 |
| Merck | 9 | $145 |
| Impulse Dynamics (USA) Inc. | 4 | $135 |
| Johnson & Johnson | 4 | $131 |
| Actelion Pharmaceuticals US, Inc. | 3 | $126 |
| E.r. Squibb & Sons, L.L.C. | 8 | $121 |
| Biosense Webster, Inc. | 4 | $106 |
| Biotronik Inc. | 1 | $100 |
| Edwards Lifesciences | 3 | $91 |
| Boehringer Ingelheim | 4 | $70 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $67 |
| Abbott | 3 | $61 |
| Shockwave Medical, Inc | 1 | $54 |
| Imperative Care, Inc | 2 | $46 |
| W. L. Gore & Associates, Inc. | 2 | $43 |
| AstraZeneca | 2 | $42 |
| Baxter Healthcare | 1 | $40 |
| Scpharmaceuticals Inc. | 1 | $32 |
| Lexicon Pharmaceuticals, Inc. | 2 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Amgen | 1 | $21 |
| Teleflex LLC | 1 | $20 |
| Altathera Pharmaceuticals LLC | 1 | $19 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Terumo Medical Corporation | 1 | $17 |
| Cook Medical LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Cardiva Medical, Inc. | 1 | $13 |
| Elutia, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$755
- Impella$252
- WATCHMAN Access System$120
- SYMPLICITY G3$118
How this compares
$5,131 in reported general payments places this provider in the 20th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
See all clinical cardiac electrophysiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 328 | $420,767 |
| XareltoRivaroxaban | 73 | $95,790 |
| EntrestoSacubitril/Valsartan | 19 | $25,003 |
| Praluent PenAlirocumab | 14 | $6,817 |
| Metoprolol Succinate | 575 | $6,202 |
| Propafenone Hcl | 98 | $6,005 |
| Amiodarone Hcl | 79 | $2,449 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 95 | $2,257 |
| Flecainide Acetate | 45 | $1,619 |
| Eplerenone | 19 | $1,435 |
| SotalolSotalol Hcl | 34 | $1,044 |
| Digoxin | 33 | $943 |
| Atorvastatin Calcium | 133 | $920 |
| ClopidogrelClopidogrel Bisulfate | 77 | $914 |
| Spironolactone | 108 | $687 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $555 | $420,767328 claims |
| Johnson & JohnsonXarelto | $131 | $95,79073 claims |
| NovartisEntresto | $764 | $25,00319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
Other clinical cardiac electrophysiology in Goshen
- Eric PrystowskyIndianapolis$1.1M
- Chad BonhommeWestfield$925K
- Kevin TrulockIndianapolis$402K
- Sharath VipparthyIndianapolis$114K
- Jasen GilgeIndianapolis$93K
- Vincent KeatingIndianapolis$80K
- Christopher ReedIndianapolis$80K
- Marcelle StuckyIndianapolis$76K
- Joseph SzwedIndianapolis$67K
- Krishna MalineniIndianapolis$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.